Bristol-Myers Squibb
Quality Improvement Initiative for CAR T Therapy
Pages
3
Time to read
6 mins
Publication
Language
English
Pages
3
Time to read
6 mins
Publication
Language
English
This document is an applicant guide for the Quality Improvement Initiative in CAR T Therapy (QII-CAR T), aimed at supporting healthcare organizations involved in delivering CAR T therapy for lymphoma patients. The initiative focuses on optimizing healthcare resource utilization and improving efficiency across the CAR T care continuum. It outlines the eligibility criteria for applicants, which includes healthcare professionals such as physicians, pharmacists, and nurses who are actively involved in CAR T therapy. The guide details the funding available for individual projects, which can request up to $50,000, and specifies the conditions under which the funding will be provided. Additionally, it describes the review process for applications, emphasizing the importance of project relevance, feasibility, evaluation of impact, sustainability, and transferability. Important dates for proposal submission and funding distribution are also included, along with contact information for further inquiries.